160 Health International Limited is a healthcare distribution and technology company that specializes in the wholesale and retail of pharmaceutical and healthcare products within China. Founded in 2005 and headquartered in Shenzhen, the company plays a pivotal role in connecting diverse stakeholders across the medical value chain, including business customers, healthcare institutions, medical professionals, and individual consumers. Its core business encompasses the supply of pharmaceutical products, medical supplies, and wellness items, providing comprehensive solutions under both wholesale and retail models. A distinctive feature of 160 Health International Limited is its development of the Healthcare 160 Platform—an integrated digital healthcare and wellness service platform that delivers online healthcare services, digital hospital solutions, and online marketing offerings. This digital ecosystem not only supports hospitals and clinics in their digital transformation but also empowers third-party merchants to engage more effectively with end-users. By blending traditional healthcare distribution with cutting-edge digital platforms, 160 Health International Limited supports the modernization and efficiency of China’s healthcare sector, underlining its significance in the region’s fast-evolving medical and health services landscape.
Markedsdata leveret af TwelveData og Morningstar